US · COSM
Cosmos Health Inc.
- Sector
- Healthcare · Drug Manufacturers - Specialty & Generic
- Headquarters
- Chicago, IL 60604
- Website
- cosmosholdingsinc.com
Price · as of 2024-12-31
$0.38
Market cap 10.71M
Valuation summary
Four models, one snapshot. Upside is target ÷ current − 1.
| Valuation method | Value, $ | Upside, % |
|---|---|---|
| Artificial Intelligence(AI) | $33.59 | +8,748.79% |
| Intrinsic Value(DCF) | $2.95 | +677.13% |
| Graham-Dodd Method(GD) | — | — |
| Graham Formula(GF) | — | — |
Valuation history
Annual price (USD per share) overlaid with each model's fair value. Y-axis is log scale.
| Year | Price | AI | DCF | Graham-Dodd | Graham Formula |
|---|---|---|---|---|---|
| 2010 | $7.00 | ||||
| 2011 | $4.50 | ||||
| 2012 | $2.30 | ||||
| 2013 | $10.90 | ||||
| 2014 | $6.80 | $3,081.74 | $18.23 | $71.06 | $8,691.08 |
| 2015 | $7.00 | $2,768.04 | $0.00 | $0.00 | $1,075.82 |
| 2016 | $7.80 | $576.91 | $414,433.62 | $0.00 | $0.00 |
| 2017 | $10.70 | $1,279.75 | $4,668,543.63 | $0.00 | $0.00 |
| 2018 | $3.85 | $2,091.33 | $210,586.00 | $0.00 | $0.00 |
| 2019 | $2.32 | $176.09 | $3,953.40 | $0.00 | $0.00 |
| 2020 | $5.85 | $142.69 | $1,309.84 | $0.00 | $71.14 |
| 2021 | $3.02 | $2,364.76 | $20.35 | $0.00 | $0.00 |
| 2022 | $3.54 | $65.54 | $29.70 | $0.00 | $13.04 |
| 2023 | $0.77 | $17.84 | $1.78 | $0.00 | $0.00 |
| 2024 | $0.51 | $33.59 | $0.67 | $0.00 | $0.00 |
AI valuation
Our deep-learning model estimates Cosmos Health Inc.'s (COSM) per-share fair value from quarterly fundamentals, sector trend, and historical valuation patterns.
- AI fair value
- $33.59
- Current price
- $0.38
- AI upside
- +8,748.79%
Methodology and confidence bands appear in the dedicated valuation theory section. The AI score is an estimate, not a recommendation.
Intrinsic value (DCF)
Open DCF calculatorThree textbook valuation models, recomputed daily from the latest financial statements. The DCF uses our Chepakovich model. Graham-Dodd and Graham Formula are conservative reference points.
DCF
$2.95
+677.13% upside
Graham-Dodd
—
— upside
Graham Formula
—
— upside
Peer comparison
Same-industry comparables, ranked by market cap.
| Basic Info | Model Valuation | Core Valuation | Profitability | Leverage & Liquidity | Growth | Cash Flow | Dividends | Enterprise Value | Risk | ||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ticker | Company Name | Price | Market Cap | AI Upside | DCF Upside | GD Upside | GF Upside | P/E | P/B | P/S | EV/EBITDA | PEG | P/TBV | Gross Margin | Operating Margin | Net Margin | ROE | ROIC | ROA | Debt/Equity | Interest Coverage | Current Ratio | Quick Ratio | Net Debt/EBITDA | EPS Growth | Sales Growth | FCF Growth | FCF Yield | Op Cash Flow Ratio | Cash ROIC | Dividend Yield | Dividend Payout | Shareholder Yield | EV/EBIT | EV/FCF | EV/Sales | Altman Z-Score |
| COSM | Cosmos Health Inc. | $0.38 | 10.71M | +8,749% | +677% | — | — | -0.61 | 0.40 | 0.18 | -1.53 | — | 0.59 | 7.92% | -28.56% | -29.73% | -53.43% | -38.56% | -26.90% | 0.48 | -15.36 | 0.99 | 0.63 | -0.83 | -4558.00% | 197.00% | -6720.00% | -82.82% | -0.30 | -20.18% | 63.07% | -38.30% | 63.07% | -1.37 | -2.62 | 0.39 | -2.69 |
| CASI | CASI Pharmaceuticals, Inc… | $0.21 | 3.21M | +5,727% | +324% | — | +8,512% | -0.86 | 18.23 | 1.18 | -1.14 | -3.22 | 20.92 | 39.06% | -138.84% | -137.57% | -301.80% | -351.62% | -60.89% | 11.96 | -45.49 | 1.09 | 0.86 | -0.25 | 2673.00% | -1577.00% | 3267.00% | -87.31% | -0.80 | -261.48% | 2.13% | -1.80% | 2.13% | -1.00 | -1.35 | 1.39 | -19.70 |
| CLSD | Clearside Biomedical, Inc… | $0.41 | 2.15M | +4,171% | +1,944,915% | — | +116,036% | -1.99 | -1.76 | 41.15 | -4.15 | — | -1.76 | 91.05% | -1735.70% | -2064.42% | 125.45% | 701.36% | -116.16% | -1.35 | -2.95 | 4.44 | 4.28 | 0.79 | -1132.00% | -7977.00% | 2894.00% | -37.50% | -5.15 | 623.48% | 0.00% | 0.00% | 48.77% | -3.49 | -3.93 | 60.65 | -22.09 |
| FEMY | Femasys Inc. | $0.57 | 16.78M | +4,489% | +5% | — | — | -1.78 | 14.49 | 20.50 | -2.29 | — | 14.92 | 66.55% | -1091.75% | -1155.03% | -182.18% | -369.29% | -93.61% | 3.23 | -11.09 | 0.93 | 0.46 | -0.24 | -968.00% | 5197.00% | 7686.00% | -60.49% | -2.27 | -419.54% | 0.00% | 0.00% | 0.00% | -2.10 | -1.85 | 22.95 | -16.97 |
| IINN | Inspira Technologies Oxy … | $0.58 | 13.97M | — | — | — | — | -1.42 | 3.64 | — | -1121.82 | — | 3.64 | 0.00% | — | — | -219.74% | 7.39% | -127.19% | 0.58 | — | 2.02 | 1.71 | 234.68 | -9994.00% | — | -426.00% | -60.68% | -2.78 | -6254.43% | 0.00% | 0.00% | 0.00% | 1104.79 | -1.31 | — | -8.52 |
| LSTA | Lisata Therapeutics, Inc. | $4.10 | 36.16M | — | -69% | — | — | -0.98 | 0.66 | 19.66 | 0.52 | — | 0.67 | 100.00% | -2240.90% | -1998.50% | -51.43% | 1147.42% | -44.56% | 0.00 | — | 6.16 | 5.73 | 0.72 | -698.00% | — | -337.00% | -98.47% | -3.45 | 1030.67% | 0.00% | 0.00% | 0.00% | 0.51 | 0.59 | -11.45 | -20.94 |
| MTVA | MetaVia Inc. | $1.51 | 3.32M | — | — | — | — | -0.44 | 1.52 | — | 0.13 | -0.97 | 1.52 | 0.00% | — | — | -224.18% | 426.89% | -141.35% | 0.02 | — | 1.94 | 1.94 | 0.55 | 4472.00% | — | 12784.00% | -205.58% | -2.99 | 366.27% | 0.00% | 0.00% | 0.00% | 0.13 | 0.16 | — | -16.10 |
| NCNA | NuCana plc | $2.16 | 13.12M | — | — | — | — | -41.51 | 132.44 | — | -34.78 | — | 210.00 | 0.00% | — | — | -182.30% | 1515.50% | -89.22% | 0.03 | — | 1.42 | 1.31 | 0.29 | -3771.00% | — | -2789.00% | -2.46% | -2.21 | 1524.22% | 0.00% | 0.00% | 0.00% | -34.28 | -40.29 | — | 27.59 |
| NXGL | NEXGEL, Inc. | $1.15 | 12.25M | +3,170% | +17,257% | — | — | -5.85 | 3.34 | 2.21 | -6.97 | — | 5.03 | 31.63% | -40.91% | -37.76% | -62.78% | -61.44% | -31.34% | 0.49 | -43.88 | 2.07 | 1.11 | -0.35 | -1071.00% | 11247.00% | 961.00% | -22.44% | -1.57 | -74.51% | 0.00% | 0.00% | 0.00% | -5.69 | -4.69 | 2.33 | 0.07 |
| PASG | Passage Bio, Inc. | $9.12 | 28.99M | — | — | — | — | -0.43 | 0.45 | — | 0.38 | — | 0.45 | 0.00% | — | — | -75.07% | -423.28% | -51.21% | 0.42 | — | 4.07 | 3.96 | 0.19 | -4250.00% | — | -3880.00% | -172.71% | -2.48 | -288.54% | 0.00% | 0.00% | 60.04% | 0.33 | 0.49 | — | -10.18 |
| SCYX | SCYNEXIS, Inc. | $0.75 | 31.47M | +6,873% | -20% | — | +4,875% | -2.21 | 0.85 | 12.54 | -0.21 | — | 0.85 | 100.00% | -990.84% | -568.29% | -33.25% | -288.55% | -19.44% | 0.30 | -14.53 | 3.00 | 2.89 | -0.01 | -13165.00% | -9733.00% | -13991.00% | -51.13% | -1.00 | -186.64% | 0.00% | 0.00% | 0.00% | -0.11 | -0.16 | 1.05 | -5.70 |
About Cosmos Health Inc.
Cosmos Health Inc. operates as a vertically integrated pharmaceutical company. It offers a proprietary line of branded and generic pharmaceuticals, nutraceuticals, over-the-counter medications, health care and baby products, medical devices, and other products through its distribution channels and an ecommerce marketplace. The company identifies, acquires, develops, and commercializes products that enhance patients' lives and outcomes, as well as has distribution centers in Greece and the United Kingdom; and operates a warehousing facility. It serves wholesale pharmaceutical distributors and independent retail pharmacies. Cosmos Health Inc. was incorporated in 2009 and is headquartered in Chicago, Illinois.
- CEO
- Grigorios Siokas
- Employees
- 149
- Beta
- 4.47
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Upside computed as ($2.95 ÷ $0.38) − 1 = +677.13% (DCF, example).